戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  profile with no signs of toxicity following intratracheal administration.
2 mor tissues persisted at least 14 days after intratracheal administration.
3 mor-targeted gene delivery in the setting of intratracheal administration.
4 ion, specifically in the upper airways after intratracheal administration.
5 vivo models in two species via intranasal or intratracheal administration.
6 riction and inflammation assays in rat after intratracheal administration.
7 iction and inflammation assays in rats after intratracheal administration.
8 targeted drug delivery through intranasal or intratracheal administration.
9                                         Upon intratracheal administration, algae-NP(DOX)-robots effic
10 oth in vivo in the airway tract of mice upon intratracheal administration, and in vitro in bronchial
11 % lower in Abcc1 ((-/-)) rats, whereas after intratracheal administration, AUC(lung) was 352% higher
12  of M(pro) in the lungs of living mice after intratracheal administration but also permits optical ur
13  injection was performed in C57BL6 mice with intratracheal administration by Candida albicans or phos
14                               In conclusion, intratracheal administration is an effective method of M
15    Sixteen rats were studied 3 days after an intratracheal administration of 5 x 10(9) to 1 x 10(11)
16                                              Intratracheal administration of a monoclonal Fas-activat
17                                          The intratracheal administration of a perfluorocarbon liquid
18         In cyclophosphamide-treated animals, intratracheal administration of a TNF-alpha agonist pept
19                                 Furthermore, intratracheal administration of Ad-Stat3-EVA caused sign
20  acute inflammatory responses in the lung to intratracheal administration of Ad.
21                                              Intratracheal administration of Ad5-HO-1 resulted in a t
22                                        After intratracheal administration of AdCMVbetagal, expression
23                                One day after intratracheal administration of AdCMVeNOS to eNOS(-/-) m
24                                        After intratracheal administration of adenoviral vectors expre
25  Clenoliximab) on immune functions following intratracheal administration of adenoviral vectors in mu
26                                          The intratracheal administration of AdMIP-1alpha resulted in
27                                              Intratracheal administration of AdRSVCGRP, followed by 1
28                                              Intratracheal administration of AdRSVeNOS attenuated the
29 odynamically, and animals were randomized to intratracheal administration of aerosolized AAV1 carryin
30 ic K-rasG12D allele that can be activated by intratracheal administration of an adenovirus expressing
31 cellular influx in the lung airway following intratracheal administration of an N-[1-(2-3-dioleyloxy)
32 lpha was induced in the lungs in response to intratracheal administration of Aspergillus fumigatus co
33 e to mainstream CS increases AHR after acute intratracheal administration of Aspergillus fumigatus ex
34  highly susceptible to lung injury caused by intratracheal administration of AV1-GFP, an early (E) re
35                 Lung fibrosis was induced by intratracheal administration of BLEO (1 U/kg) to wild-ty
36                                              Intratracheal administration of bleomycin in wild-type a
37                                              Intratracheal administration of bleomycin led to caspase
38 F-beta1) is a critical mediator of ALI after intratracheal administration of bleomycin or Escherichia
39                                     A single intratracheal administration of CCL21 gene-modified dend
40 ved in antibacterial defenses, and exogenous intratracheal administration of CG combined with NE does
41 nes MIP-2 and KC were induced in response to intratracheal administration of conidia.
42                  In anesthetized guinea pigs intratracheal administration of DEPs activated airway C-
43 eolar repair and the phenotype is rescued by intratracheal administration of DNase I.
44                                              Intratracheal administration of either SCW or SLO alone
45                      Twenty-four hours after intratracheal administration of Escherichia coli lipopol
46                                              Intratracheal administration of exogenous IFN-gamma to L
47                                              Intratracheal administration of GM-CSF induced final rAM
48                              Two hours after intratracheal administration of HCl, W/D increased from
49 a clinically relevant mouse model induced by intratracheal administration of hydrochloric acid and li
50                                              Intratracheal administration of IL-17 provoked a neutrop
51 ion of the lungs of CBA/J mice following the intratracheal administration of K. pneumoniae (7 x 10(2)
52 te that HFH-11 mRNA levels are stimulated by intratracheal administration of keratinocyte growth fact
53        In initial studies, we found that the intratracheal administration of Klebsiella pneumoniae in
54                                              Intratracheal administration of lead compound 26 resulte
55         Methods: ALI was induced by a single intratracheal administration of lipopolysaccharide (10,
56         Methods: ALI was induced by a single intratracheal administration of lipopolysaccharide (10,
57                   Lung injury was induced by intratracheal administration of lipopolysaccharide (5 mg
58           Lung inflammation was induced with intratracheal administration of lipopolysaccharide (LPS)
59 gs) in mouse lung experimentally inflamed by intratracheal administration of lipopolysaccharide.
60              Depletion of macrophages by the intratracheal administration of liposomal clodronate att
61                In this study, we report that intratracheal administration of LMW HA (200 kDa) causes
62                                              Intratracheal administration of low molecular mass (LMM)
63                                              Intratracheal administration of LPA in mice resulted in
64                                              Intratracheal administration of LPS (1 mg/kg) in WT mice
65 lation of neuraminidase (NA) 30 min prior to intratracheal administration of LPS increased polymorpho
66 phil accumulation in the airspaces following intratracheal administration of LPS.
67 nfections were initiated through noninvasive intratracheal administration of M. avium 724 in mice ind
68                                              Intratracheal administration of ManLAM in mice resulted
69 antly reduced in C57BL/6 mice after a single intratracheal administration of modified vectors, and le
70 ction could be achieved in the lung from the intratracheal administration of mRNA.
71 ct (HIV-LTR/luciferase (HLL)), we found that intratracheal administration of P. aeruginosa resulted i
72 bited augmented clearance 3 and 7 days after intratracheal administration of P. murina, which correla
73 nction of AM, C57BL/6 mice received low-dose intratracheal administration of pneumococci.
74 sceptible throughout 8 wk to infection after intratracheal administration of Pseudomonas aeruginosa;
75                                          The intratracheal administration of Pseudomonas to mice resu
76                                              Intratracheal administration of rat recombinant IL-18 in
77                                              Intratracheal administration of recombinant mouse comple
78                                     However, intratracheal administration of recombinant murine IL-12
79 er examined the effect of IGFBP-5 in vivo by intratracheal administration of replication-deficient ad
80                                              Intratracheal administration of rmCIRP into WT mice sign
81                                              Intratracheal administration of SCP with either SCW or S
82                                              Intratracheal administration of silica was also able to
83 nhibition of Fas gene expression in lungs by intratracheal administration of small interfering RNA co
84                                              Intratracheal administration of SP-A to SP-A(-/-) mice e
85                                              Intratracheal administration of Sph3h was well tolerated
86 ospholipids were found to increase following intratracheal administration of tBuOOH (36 mg/kg), but n
87  expression of FcgammaRIIA in the lung after intratracheal administration of the AdFcgammaRIIA enhanc
88 n and widespread lung distribution following intratracheal administration of the formulations.
89                                              Intratracheal administration of the natural antagonist o
90 y drug accumulation in lungs and blood after intratracheal administration of the spray dried inhalabl
91                                              Intratracheal administration of these agents concurrentl
92                                              Intratracheal administration of this vector delivering m
93 rachea of wild-type and Cxcr2(-/-) mice, but intratracheal administration of TNFalpha did not induce
94 ts, pulmonary gene transfer was performed by intratracheal administration of various amounts of an ad
95                                              Intratracheal administration of Wnt3a or an antibody cap
96  experimental model used herein entailed six intratracheal administrations of methylnitrosourea (MNU)
97                                    Following intratracheal administration, OVA-specific CD4(+)CD25(+)
98              However, the invasive nature of intratracheal administration poses barriers to its clini
99                                        Their intratracheal administration resulted in increased airwa